Effect of diabetes on endometrial cancer recurrence and survival

Maturitas

Volumn 74, Issue 1, 2013, Pages 37-43

  Zanders, Marjolein M J ^a,b   Boll, Dorry ^c   Van Steenbergen, Liza N ^b   Van De Poll Franse, Lonneke V ^b,d   Haak, Harm R ^a  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c CPRLab   (Netherlands)

^d TILBURG UNIVERSITY   (Netherlands)

Author keywords

Cancer Registry; Diabetes mellitus; Disease specific Mortality; Endometrial cancer; Population based study

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; ENDOMETRIUM CANCER; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL;

AGED; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE;

EID: 84870938705     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.10.007     Document Type: Article

References (36)

1. A.N. Fader, L.N. Arriba, H.E. Frasure, and V.E. von Gruenigen Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship Gynecologic Oncology 114 1 2009 121 127
2. E. Friberg, N. Orsini, C.S. Mantzoros, and A. Wolk Diabetes mellitus and risk of endometrial cancer: a meta-analysis Diabetologia 50 7 2007 1365 1374
3. E. Giovannucci, D.M. Harlan, and M.C. Archer Diabetes and cancer: a consensus report CA: A Cancer Journal for Clinicians 60 4 2010 207 221
4. K. Lindemann, L.J. Vatten, M. Ellstrom-Engh, and A. Eskild Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study British Journal of Cancer 98 9 2008 1582 1585
5. L. Wedisinghe, and M. Perera Diabetes and the menopause Maturitas 63 3 2009 200 203
6. F. Bray, I. Dos Santos Silva, H. Moller, and E. Weiderpass Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention Cancer Epidemiology, Biomarkers and Prevention 14 5 2005 1132 1142
7. F.A. Sloan, M.A. Bethel, D. Ruiz, A.M. Shea, and M.N. Feinglos The growing burden of diabetes mellitus in the US elderly population Archives of Internal Medicine 168 2 2008 192 199 discussion 199
8. Cancer in the Netherlands till 2020 Trends and prognoses 2011 Signalling Committee Cancer of the Dutch Cancer Society Amsterdam ISBN: 90-71229-00-8
9. Baan CA, Schoemaker CG, Jacobs-van der Bruggen MAM, et al. Diabetes tot 2025; preventie en zorg in samenhang. RIVM-rapport 260322004; 2009.
10. Cancer in the Netherlands Trends, prognoses and implications for healthcare 2004 Signalling Committee Cancer of the Dutch Cancer Society Amsterdam 90-71229-13-0
11. B.B. Barone, H.C. Yeh, and C.F. Snyder Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis JAMA 300 23 2008 2754 2764
12. V.M. Chia, P.A. Newcomb, A. Trentham-Dietz, and J.M. Hampton Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis International Journal of Gynecological Cancer 17 2 2007 441 446
13. A.R. Folsom, K.E. Anderson, C. Sweeney, and D.R. Jacobs Jr. Diabetes as a risk factor for death following endometrial cancer Gynecologic Oncology 94 3 2004 740 745
14. E. Steiner, O. Eicher, and J. Sagemuller Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University International Journal of Gynecological Cancer 13 2 2003 197 203
15. L.V. van de Poll-Franse, S. Houterman, M.L. Janssen-Heijnen, M.W. Dercksen, J.W. Coebergh, and H.R. Haak Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis International Journal of Cancer 120 9 2007 1986 1992
16. D. Boll, R.H. Verhoeven, M.A. van der Aa, M.L. Lybeert, J.W. Coebergh, and M.L. Janssen-Heijnen Adherence to national guidelines for treatment and outcome of endometrial cancer stage I in relation to co-morbidity in southern Netherlands 1995-2008 European Journal of Cancer 47 10 2011 1504 1510
17. J.A. Johnson, B. Carstensen, D. Witte, S.L. Bowker, L. Lipscombe, and A.G. Renehan Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence Diabetologia 55 6 2012 1607 1618
18. A.G. Renehan, H.C. Yeh, J.A. Johnson, S.H. Wild, E.A. Gale, and H. Moller Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer Diabetologia 55 6 2012 1619 1632
19. L.D. Zuurendonk, R.A. Smit, and B.W. Mol Routine pelvic lymphadenectomy in apparently early stage endometrial cancer European Journal of Surgical Oncology 32 4 2006 450 454
20. www.oncoline.nl. National Dutch guideline of endometrial cancer; 2011.
21. C.L. Creutzberg, W.L. van Putten, and P.C. Koper Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial, PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 9213 2000 1404 1411
22. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation Journal of Chronic Diseases 40 5 1987 373 383
23. International classification of diseases of oncology. Version 2007 1st ed. 1976 WHO Geneva
24. C. van Duijn, and I. Keij Sociaal-economische status indicator op postcode niveau Maandstatistiek van de bevolking 50 2 2002 32 35
25. J.V. Bokhman Two pathogenetic types of endometrial carcinoma Gynecologic Oncology 15 1 1983 10 17
26. W.T. Creasman, F. Odicino, and P. Maisonneuve Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer International Journal of Gynecology and Obstetrics 95 Suppl. 1 2006 S105 S143
27. D. Boll, R.H.M. Hermans, and K.G.G. Keijser Bundeling Regionale Expertise Gynaecologische Oncologie Medisch Contact 64 21 2009 942 945
28. M.P. van Herk-Sukel, L.V. van de Poll-Franse, and V.E. Lemmens New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System European Journal of Cancer 46 2 2010 395 404
29. R.J. Kurman, L.H. Ellenson, and B.M. Ronnett Blaustein's pathology of the female genital tract 6th ed. 2011 Springer-Verlag New York, NY
30. H.S. Moon, J.P. Chamberland, K. Aronis, S. Tseleni-Balafouta, and C.S. Mantzoros Direct role of adiponectin and adiponectin receptors in endometrial cancer: in vitro and ex vivo studies in humans Molecular Cancer Therapeutics 10 12 2011 2234 2243
31. A.E. Cust, R. Kaaks, and C. Friedenreich Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women Journal of Clinical Endocrinology and Metabolism 92 1 2007 255 263
32. P. Vigneri, F. Frasca, L. Sciacca, G. Pandini, and R. Vigneri Diabetes and cancer Endocrine-Related Cancer 16 4 2009 1103 1123
33. L.A. Cantrell, C. Zhou, A. Mendivil, K.M. Malloy, P.A. Gehrig, and V.L. Bae-Jump Metformin is a potent inhibitor of endometrial cancer cell proliferation - implications for a novel treatment strategy Gynecologic Oncology 116 1 2010 92 98
34. S.H. Olson, C.L. Atoria, and M.L. Cote The impact of race and comorbidity on survival in endometrial cancer Cancer Epidemiology, Biomarkers and Prevention 21 5 2012 753 760
35. W. Demark-Wahnefried, K.L. Campbell, and S.C. Hayes Weight management and its role in breast cancer rehabilitation Cancer 118 8 Suppl. 2012 2277 2287
36. M.L. Janssen-Heijnen, S. Houterman, V.E. Lemmens, M.W. Louwman, H.A. Maas, and J.W. Coebergh Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach Critical Reviews in Oncology/Hematology 55 3 2005 231 240